Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc. Pavmed currently holds 31,302,444 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Pavmed has been a net buyer of LUCD stock. They have purchased $8.0M and sold $0 worth of shares.
Inc. Pavmed's most recent insider trade was on Feb 15, 2024, when they sold 3,331,747 shares at $0.00 per share.
Inc. Pavmed serves as Executive at Lucid Diagnostics Inc. (LUCD). They have executed 13 insider transactions totaling $8.0M over their tenure at the company.
Inc. Pavmed holds the position of Executive at Lucid Diagnostics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Inc. Pavmed has shown a buying trading pattern, with $8.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Inc. Pavmed was on Oct 18, 2021, when they purchased $8.0M worth of LUCD shares. This transaction involved 571,428 shares at $14.00 per share.
Inc. Pavmed currently owns 31,302,444 shares of Lucid Diagnostics Inc. (LUCD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc. Pavmed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc. Pavmed has 13 Form 4 filings on record as an insider at Lucid Diagnostics Inc..
Set alerts for Inc. Pavmed and 40,000+ other insiders.